European Society of Toxicology In Vitro > News > ESTIV and ONTOX signs Memorandum of Understanding
29 October 2021

ESTIV and ONTOX signs Memorandum of Understanding

Scope of Collaboration

ESTIV and ONTOX entered into the MoU to jointly conduct the following activities:

  • to share appropriate information related to the activities in the field of research on NAMs to adequate target audiences
  • to jointly organise events with clear mutual benefits for ESTIV and for ONTOX.

The MoU has been signed on 19 October 2021 by ESTIV President, Dr. Helena Kandarova and ONTOX Project Coordinator, Prof. Mathieu Vinken (VUB).


ONTOX is conducting a research project in the context of the European H2020 Research and Innovation Programme SC1-BHC-11-2020 called “Advancing the safety assessment of chemicals without the use of animal testing”. The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st century toxicity testing and next generation risk assessment. More at: www.ontox-project.eu

Related content

Be aware of scammers…..

Please be aware, that ESTIV and many other EU-based societies are currently facing the incased activity of scams and fraudulent e-mails requesting bank transfers to various accounts. ….

ASCCT-ESTIV special webinar for Ukraine: Science for Policy, Policy for Science – May 25, 2022

ESTIV and ASCCT joined forces and organise a special webinar to support Ukraine….

Advancing In Vitro Models for Genotoxicity and Carcinogenicity – May 16, 2022

Please join us on Monday May 16 at 17:00 for our next joint ESTIV-ASCCT webinar: Advancing In Vitro Models for Genotoxicity and Carcinogenicity
featuring Anouck Thienpont, PhD Student, VUB Belgium and Dr. Silvia Scaglione, React4life (ESTIV Corporate member) and the winner of the GammaDonna award 2021.

Gold Sponsor

Silver Sponsor

Corporate Members

Affiliated Societies

Memorandum of Understanding